4//SEC Filing
Busch Jeffrey 4
Accession 0001104659-23-026874
CIK 0001533615other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:18 PM ET
Size
6.5 KB
Accession
0001104659-23-026874
Insider Transaction Report
Form 4
Busch Jeffrey
DirectorChairman, President and CEO
Transactions
- Award
LTIP Unit (Right to Buy)
2023-02-28+13,175→ 629,842 total→ Common Stock (13,175 underlying)
Footnotes (2)
- [F1]Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2023, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2022 and February 28, 2023 and 50% of the LTIP Units will vest on February 28, 2024 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.
- [F2]As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.
Documents
Issuer
Global Medical REIT Inc.
CIK 0001533615
Entity typeother
Related Parties
1- filerCIK 0001620772
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:18 PM ET
- Size
- 6.5 KB